|
FY2025
12 months to Dec 31, 2025
|
FY2024
6 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net income | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Changes in operating assets and liabilities: | ||
| Accounts payable | ||
| Prepaid expenses | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Investment in trust account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from promissory note | ||
| Repayment of promissory note | ||
| Proceeds from issuance of Founder shares | ||
| Proceeds from sale of 23,000,000 units at $10 per unit in IPO net of offering cost | ||
| Proceeds from sale in private placements | ||
| Sponsor | ||
| Underwriter | ||
| Proceeds from sale of 1,000,000 $15 strike warrants in private placement | ||
| Net cash provided by Financing activities | ||
| Net increase in cash | ||
| Cash at beginning of period | ||
| Cash at end of period | ||
| Supplemental disclosure for non-cash financing activities: | ||
| Settlement of additional Founder Share issuance against the promissory note | ||
| Offering cost |
Loading...
